Discover the booming (1-3)-β-D-Glucan Assay market! Our analysis reveals a $250 million market in 2025, projected to grow at 8% CAGR until 2033, driven by rising fungal infection rates and advanced diagnostic technology. Learn about key players, market segments, and future trends.
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.
